Total Payments
$3,723
2024 Payments
$1,094
Companies
39
Transactions
230
Medicare Patients
4,352
Medicare Billing
$160,282
Payment Breakdown by Category
Food & Beverage$3,723 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,723 | 230 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $796.26 | 48 | $0 (2024) |
| Lilly USA, LLC | $547.25 | 37 | $0 (2024) |
| Amgen Inc. | $241.56 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $198.74 | 11 | $0 (2024) |
| PFIZER INC. | $193.68 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $188.79 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $167.04 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $162.59 | 10 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $138.47 | 8 | $0 (2022) |
| Novo Nordisk Inc | $132.30 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,094 | 62 | ABBVIE INC. ($354.40) |
| 2023 | $939.26 | 58 | ABBVIE INC. ($241.30) |
| 2022 | $851.86 | 56 | Lilly USA, LLC ($176.13) |
| 2021 | $837.51 | 54 | Amarin Pharma Inc. ($132.20) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: PAIN | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Biological | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: PAIN | ||||||
| 08/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Neuroscience | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.06 | General |
| 07/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 1,540 | 1,943 | $139,992 | $57,298 |
| 2022 | 35 | 1,954 | 2,423 | $168,737 | $71,478 |
| 2021 | 20 | 773 | 876 | $56,802 | $31,108 |
| 2020 | 2 | 85 | 129 | $1,443 | $398.48 |
Total Patients
4,352
Total Services
5,371
Medicare Billing
$160,282
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 326 | $43,358 | $15,998 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 176 | $32,032 | $10,897 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $14,696 | $5,583 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $9,234 | $5,521 | 59.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $4,112 | $2,136 | 51.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 149 | 228 | $1,596 | $1,538 | 96.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 21 | $1,680 | $1,497 | 89.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,572 | $1,468 | 32.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 25 | 25 | $1,875 | $1,257 | 67.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 64 | 71 | $2,982 | $1,169 | 39.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 84 | 102 | $2,754 | $1,047 | 38.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 100 | 135 | $1,890 | $1,027 | 54.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 54 | 58 | $1,740 | $895.66 | 51.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 59 | 68 | $2,244 | $855.96 | 38.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 18 | $1,800 | $833.76 | 46.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 20 | 42 | $1,260 | $625.72 | 49.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 50 | 64 | $1,536 | $584.21 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,411 | $579.52 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 22 | $704.00 | $557.26 | 79.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 44 | 52 | $1,040 | $411.32 | 39.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $448.00 | $349.02 | 77.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 16 | 16 | $646.00 | $302.72 | 46.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 18 | $648.00 | $240.48 | 37.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 16 | 16 | $624.00 | $236.48 | 37.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 22 | $726.00 | $235.52 | 32.4% |
About Carson Close, PA-C
Carson Close, PA-C is a Physician Assistant healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2015. The National Provider Identifier (NPI) number assigned to this provider is 1073981437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carson Close, PA-C has received a total of $3,723 in payments from pharmaceutical and medical device companies, with $1,094 received in 2024. These payments were reported across 230 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,723).
As a Medicare-enrolled provider, Close has provided services to 4,352 Medicare beneficiaries, totaling 5,371 services with total Medicare billing of $160,282. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Ogden, UT
- Active Since 09/02/2015
- Last Updated 05/07/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1073981437
Products in Payments
- VRAYLAR (Drug) $398.61
- NURTEC ODT (Drug) $338.90
- MOUNJARO (Drug) $330.78
- QULIPTA (Drug) $196.00
- Vascepa (Drug) $188.79
- EVENITY (Biological) $178.38
- UBRELVY (Drug) $152.59
- SPRAVATO (Drug) $139.93
- JARDIANCE (Drug) $123.69
- TRELEGY ELLIPTA (Drug) $111.49
- Heplisav-B (Drug) $83.90
- Ozempic (Drug) $71.97
- BREZTRI (Drug) $67.83
- FARXIGA (Drug) $64.61
- Otezla (Drug) $63.18
- TRULICITY (Drug) $61.91
- SOLIQUA 100/33 (Biological) $58.04
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $50.39
- XARELTO (Drug) $45.88
- Xofluza (Drug) $45.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ogden
Jenna Rhoton, Pa-C, PA-C
Physician Assistant — Payments: $24,162
Physician Assistant $24,162
Kylie Money, Pa-C, PA-C
Physician Assistant — Payments: $22,338
Physician Assistant $22,338
Nathan Mcbride, Pa C, PA C
Physician Assistant — Payments: $8,098
Physician Assistant $8,098
Brennon Flannery, Pa-C, PA-C
Physician Assistant — Payments: $7,226
Physician Assistant $7,226
Molli Neilson, Pa-C, PA-C
Physician Assistant — Payments: $7,045
Physician Assistant $7,045
Eric Johnson, Pa-C, PA-C
Physician Assistant — Payments: $3,816
Physician Assistant $3,816